Furthermore, King et al. [65] demonstrated that mutations in Fbxw7 specifically enhanced cancer-initiating cell activity in collaboration with Notch1 oncogenes in a model of T-cell acute lymphoblastic leukemia but spared normal hematopoietic stem cell function. Here, FBXW7 is linked to T-cell acute lymphoblastic leukemia.